The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

BPAP Intervention Flops in Asthma Study

Goal of decreasing the duration of beta-agonist therapy in the ED showed no significant effect

To Face Scrutiny at ESC: Statins for the Elderly, New Heart Attack Therapies

STAREE trial will give its verdict on primary prevention statins in people ages 70 and up

Radio Silence on Mitch McConnell's Health Persists

84-year-old senator hasn't been seen in public since his hospitalization nearly 3 months ago

Cefepime Tied to Higher Mortality Odds vs Other Beta-Lactams

The danger may be in the dosing, not in the drug itself

Real-World U.S. Data Back Azithromycin After Unscheduled C-Sections

Postpartum infection rates decreased after landmark 2016 study

Study Warns on Multidrug-Resistant Yeast on Hospital Workers' Gloves, Gowns

C. auris transfer rates topped those of more familiar pathogens

Todays Updates

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Todays Updates

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Latest News

Goal of decreasing the duration of beta-agonist therapy in the ED showed no significant effect

STAREE trial will give its verdict on primary prevention statins in people ages 70 and up

84-year-old senator hasn't been seen in public since his hospitalization nearly 3 months ago

The danger may be in the dosing, not in the drug itself

Postpartum infection rates decreased after landmark 2016 study

C. auris transfer rates topped those of more familiar pathogens

News All Time

Omalizumab May Ease Inflammation in Chronic Urticaria

In patients with antihistamine-resistant chronic spontaneous urticaria, omalizumab treatment is linked to clinical improvement and reduced systemic inflammatory markers and D-dimer levels.

Pediatric Lung Transplantation Enters a New Era

New CFTR modulators are reshaping pediatric lung transplantation, forcing clinicians to rethink when children should be referred and listed.

CVS Health's Aetna to Streamline Cancer Treatment Approvals

CVS Health's Aetna health insurance unit will cut back next year on the preapprovals it requires for treatment ⁠for cancer patients to only one medical prior authorization...

Diphtheria Debate Exposes Health Misinformation

A diphtheria death in Sicily has reignited debate over vaccines, migration, and how political spin can distort public health facts.

Azithromycin Use Cuts Cesarean Infections

Azithromycin has been shown to lower the risk for postoperative infection during cesarean deliveries when added to more standard prophylactics such as cefazolin.

Methotrexate for IBD: How Do GIs Use It?

A new study offers the most comprehensive real-world look yet at methotrexate use in treating IBD in everyday practice.

AI Digital Twins Get Better and Better: Cancer in Crosshairs

Digital twins allow doctors to simulate treatment to see what will work best — and the tech has made real strides in cardiology. Oncology remains the bigger challenge.

Host-Directed Therapies and Phages in Lung Care

Host-directed and phage therapies are emerging as alternatives to antibiotics in managing lung infections in a worsening antimicrobial resistance crisis.

S1P Modulators: 5 Agents, One Safety Playbook

Five S1P modulators now span neurology and GI. Bruce Cree, MD, PhD, and others weigh in on why selectivity differences are no longer academic.

As-Needed Allergic Rhinitis Meds Comparable to Daily Use

Patients with allergic rhinitis who use medication as needed can achieve symptom control and treatment satisfaction comparable to those achieved by patients who use them daily.

Mild Brain Injury Frequently Missed in the ED

Only 21% of adults with closed head injury have mTBI diagnosed or clinically suspected in the ED, despite 41% meeting diagnostic criteria, with missed diagnoses most common among middle-aged adults.

A Rare Hearing Implant Bypasses Damaged Nerves

When cochlear implants failed, doctors turned to a brainstem auditory implant to restore sound awareness in a patient with profound deafness.

D10 Matches D50 for Hypoglycemia, Shows Lower Rebound Risk

A lower-concentration dextrose solution matches the standard treatment for hypoglycemia in the emergency department but carries a lower risk for rebound hypoglycemia.

Two-Midnight Rule: Key Strategies for Observation Patients

The Two-Midnight Rule has created important clinical and operational strategies for hospitals.

Pediatric Atopic Dermatitis: Biologic Revolution Continues

The pediatric atopic dermatitis treatment landscape expands as new biologics emerge, and researchers ask whether earlier intervention can change the course of disease.

AAD Issues Guidelines on Treatment-Refractory Adult Eczema

Experts suggest a more ‘whole person’ differential diagnosis when adults do not respond to atopic dermatitis treatment.

Recommended News For You

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

PSA Screening Overdiagnosis Rises Sharply With Age

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

Hemihedral resection not necessary for neuroendocrine surgery after appendicitis

PSA Often Unchanged With Enzalutamide Progression

Breast Cancer Patients Living Longer Post-Medicaid Expansion

Recommended Articles For You

Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself 

Screening for Early Red-Cell Deformability Changes: Clinical Relevance, Mechanisms, and Emerging Diagnostics 

Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment 

Case Study: Genomic Medicine in Precision Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?

2.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

3.

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

4.

GLP-1 receptor agonists, cancer risk and questionable significance

5.

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

1.

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment

2.

Gynecologic Oncology: Advances, Education, and Clinical Excellence

3.

Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology

4.

Strategic Developments in Hematology and Quality Improvement

5.

Altered Marrow Cell-Production Dynamics During Chronic Hematologic Stress

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

3.

Navigating the Complexities of Ph Negative ALL - Part I

4.

Current Scenario of Cancer- The Incidence of Cancer in Men

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot